InsidersTradesSigma
Browse the detailed record of transactions filed by Mann William Roland, Chief Executive Officer. Director active across 1 company, notably NeuBase Therapeutics, Inc.. Cumulatively, 1 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €11k. Activity tracked since 30 March 2022. The latest transaction was filed on 30 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
William Roland Mann is the Chief Operating Officer of NeuBase Therapeutics, Inc. He is responsible for overseeing the company's daily operations and ensuring process efficiency. His role is essential for supporting growth and innovation within the organization.